The CircumBlator™ AF Catheter Ablation System is not approved for human use.
Founded in 2013, AblaCor (formerly known as Automated Medical Instruments, Inc.) is an early-stage medical device company located in a suburb of Boston, MA. Our first product is the CircumBlator™ AF Catheter Ablation System to advance pulmonary vein isolation (PVI) procedures for patients with atrial fibrillation (AFib), the most common irregular heart rhythm and a potentially deadly disorder. The CircumBlator system is designed to overcome limitations of currently available ablation catheters for AFib by producing durable, continuous, transmural lesions the first time. AblaCor has a strong portfolio of patents issued and pending.
Led by Martin Sklar, Founder and CEO, the AblaCor leadership team brings diverse expertise to the management of our company. From making decisions that guide long-term strategy to day-to-day operations, our team combines valuable medical technology leadership and R&D experience that is creating a game-changing technology.